Papers
12
Total Citations
115
H-Index
8
About
Dr. Jonathan Olivier is a leading urologic oncologist whose research focuses on advancing minimally invasive surgical treatments for prostate and kidney cancers. His major contributions center on optimizing robotic-assisted partial nephrectomy (RAPN) and stereotactic body radiation therapy (SBRT) for recurrent disease. Notably, his work on salvage re-irradiation using CyberKnife for local prostate cancer recurrence after prostatectomy (32 citations) provides critical guidance for managing this challenging clinical scenario. Through the French Kidney Cancer Research Network (UroCCR), Dr. Olivier has led multiple prospective studies demonstrating the oncological safety and functional outcomes of RAPN, including a landmark evaluation of 5-year outcomes and late complications (10 citations). His comparative effectiveness research has shown that RAPN and percutaneous ablation offer comparable outcomes for elderly patients with T1 renal cell carcinoma (12 citations). Dr. Olivier has also developed and validated the SPARE nephrometry scoring system to predict renal function after partial nephrectomy (8 citations), and his work on positive surgical margins after RAPN (14 citations) has informed surgical decision-making. His protocol for the P-NeLoP trial (6 citations) explores innovative low-pressure insufflation techniques to enhance patient recovery. With over 100 cumulative citations, Dr. Olivier’s research continues to shape evidence-based, patient-centered approaches in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10